TCL Archive CMS Considering Regulatory Standards for Drug Company Bundling of Products. October 20, 2006
TCL Archive Two More Treatment Programs Moved To DCT; Rauscher Ponders Fate of Cooperative Groups April 18, 1975
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983